Specifically, TRPM3 plays a major role in the progression of ccRCC with von Hippel-Lindau (VHL) loss mutation and has an increased expression in human ccRCC with inactivated or deleted vhl [122]. Here, VHL is linked to nonpapillary renal cell carcinoma.